An innovative project focused on creating cutting-edge precision medicine (PM) and artificial intelligence (AI) strategies for the treatment and management of multiple sclerosis (MS) has been generously funded with AU$2.9 million (roughly $1.96 million USD) by the Australian government’s Medical Research Future Fund (MRFF). With a multidisciplinary approach, this innovative study will be led by...
Tag: ClinicalResearch
Post
Ketamine’s New Role: A Slow-Release Pill for Severe Depression
Introduction: Ketamine has shown promise as a treatment for severe depression, despite its initial reputation as a party drug and horse tranquilizer. Although ketamine is often given intravenously in a clinical environment, new developments indicate that a slow-release pill may increase accessibility to this medication and lessen unpleasant side effects. This discovery may be revolutionary...